ctrl K

Watchlist Price Alert

XTL Biopharmaceuticals Lt... (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

1.22

0.10 (8.93%)

At close: Jun 16, 2025, 3:56 PM

1.20

-1.64%

Pre-market: Jun 17, 2025, 07:08 AM EDT

XTL Biopharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	451K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	448K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.17M	-765K	-880K	-1.03M	-948K	-842K	-793K	-1.25M	-2.56M
Interest Income	34K	36.00	36K	8K	33K	93K	87K	16K	n/a
Pretax Income	-1.16M	-1.78M	-1.35M	435K	-2.95M	-1.35M	2.99M	-781K	-2.54M
Net Income	-1.03M	-1.78K	-1.35M	435K	-782K	-1.35M	2.99M	-781K	-2.54M
Selling & General & Admin	2.05M	734K	850K	1M	910K	807K	755K	1.19M	1.26M
Research & Development	98K	31K	30K	30K	38K	35K	38K	43K	443K
Other Expenses	31K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.17M	765K	880K	1.03M	948K	842K	793K	1.25M	1.71M
Interest Expense	28K	n/a	n/a	n/a	n/a	29K	n/a	n/a	n/a
Selling & Marketing Expenses	178K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.62M	765K	880K	1.03M	948K	842K	793K	1.25M	1.71M
Income Tax Expense	-130K	n/a	468K	-1.47M	n/a	-69K	-80K	-457K	832K
Shares Outstanding (Basic)	6.73M	5.45M	5.45M	5.32M	5.14M	5.14M	5.14M	4.7M	2.74M
Shares Outstanding (Diluted)	7.04M	5.45M	5.45M	6.16M	5.14M	5.14M	5.14M	4.7M	2.74M
EPS (Basic)	-0.15	n/a	-0.25	0.10	-0.15	-0.26	0.58	-0.17	-0.93
EPS (Diluted)	-0.15	n/a	-0.25	0.07	-0.15	-0.26	0.58	-0.17	-0.93
EBITDA	-930K	-764K	-879K	-1.03M	-947K	n/a	-792K	-1.25M	-1.71M
EBIT	-1.13M	-765K	-880K	-1.03M	-948K	-842K	-793K	-1.25M	-1.71M
Depreciation & Amortization	199K	1K	1K	1K	1K	842K	1K	1K	3K